IRIDEX CORP Files 8-K Report

Ticker: IRIX · Form: 8-K · Filed: Sep 6, 2024 · CIK: 1006045

Iridex Corp 8-K Filing Summary
FieldDetail
CompanyIridex Corp (IRIX)
Form Type8-K
Filed DateSep 6, 2024
Risk Levellow
Pages3
Reading Time3 min
Key Dollar Amounts$0.01, $4.2 million, $2
Sentimentneutral

Sentiment: neutral

Topics: sec-filing, 8-k

Related Tickers: IRIX

TL;DR

IRIDEX CORP filed an 8-K, likely an update for investors.

AI Summary

On September 5, 2024, IRIDEX CORP filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." No specific financial figures or material events were detailed in the provided excerpt, suggesting it may be a routine filing or an update on previously disclosed information.

Why It Matters

This filing indicates IRIDEX CORP is providing updates to the SEC, which could contain material information for investors regarding the company's operations or financial status.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing notification without specific details of negative events, indicating a low immediate risk.

Key Players & Entities

  • IRIDEX CORP (company) — Registrant
  • Delaware (jurisdiction) — State of incorporation
  • 1212 Terra Bella Avenue Mountain View, California 94043 (address) — Principal executive offices

FAQ

What is the primary purpose of this 8-K filing for IRIDEX CORP?

The filing is categorized under "Other Events" and "Financial Statements and Exhibits," indicating it serves to report on these matters to the SEC.

When was this 8-K report filed?

The report was filed on September 6, 2024, with the date of the earliest event reported being September 5, 2024.

What is IRIDEX CORP's state of incorporation?

IRIDEX CORP is incorporated in Delaware.

What is the principal executive office address for IRIDEX CORP?

The principal executive offices are located at 1212 Terra Bella Avenue, Mountain View, California 94043.

Does this filing provide specific financial details or material events?

The provided excerpt does not detail specific financial figures or material events, suggesting it may be a routine or preliminary filing.

Filing Stats: 775 words · 3 min read · ~3 pages · Grade level 12.5 · Accepted 2024-09-06 06:09:55

Key Financial Figures

  • $0.01 — ch Registered Common Stock, par value $0.01 per share IRIX Nasdaq Capital Marke
  • $4.2 million — ce that will be the case. If the issued $4.2 million full face value Note were to be convert
  • $2 — nverted by Lind at the premium price of $2.44, it would result in the issuance of

Filing Documents

01 Other Events

Item 8.01 Other Events On September 5, 2024, IRIDEX Corporation (the "Company") filed a resale registration statement on Form S-3 with the Securities and Exchange Commission (the "Registration Statement"). The filing of the Registration Statement was required by the contractual obligations agreed to by the Company under the Securities Purchase Agreement, dated August 4, 2024 (the "Purchase Agreement"), by and between the Company and Lind Global Asset Management IX LLC ("Lind"). As stated on the first page of the Registration Statement, the total number of shares included within the Registration Statement represents (i) the maximum number of shares of common stock that may become issuable upon the conversion of a senior convertible promissory note, dated August 7, 2024 (the "Note" and the number of shares issuance upon conversion of the Note (the "Note Shares")) and (ii) shares of common stock that were issued pursuant to the Purchase Agreement (the "Incentive Shares"). No Note Shares have been issued to Lind and no Note Shares are currently outstanding. The number of Note Shares that may, at some future date, be issued to Lind upon conversion of the Note is subject to a number of conditions, as set forth in the Purchase Agreement and related documents, and cannot exceed the number of shares set forth in the Registration Statement. The Company believes that any Note Shares issued in connection with conversion of the Note will be substantially fewer than the maximum amount being registered in the Registration Statement but can provide no assurance that will be the case. If the issued $4.2 million full face value Note were to be converted by Lind at the premium price of $2.44, it would result in the issuance of approximately 1.7 million additional shares of common stock. For purposes of the Registration Statement, the Company has registered the maximum number of Note Shares and Incentive Shares, in the aggregate, that may be issued and resold by Lind in accordance

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). - 2 -

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934,as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IRIDEX CORPORATION By: /s/ David I. Bruce David I. Bruce Chief Executive Officer Date: September 6, 2024 - 3 -

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.